HYDROXO-B12 *1ML* SDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 1 mL Glass/Single Dose vial, Prepar...

FDA Recall #D-0721-2017 — Class II — April 18, 2017

Recall #D-0721-2017 Date: April 18, 2017 Classification: Class II Status: Terminated

Product Description

HYDROXO-B12 *1ML* SDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 1 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling Firm

Key Pharmacy and Compounding Center — Federal Way, WA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

50 vials

Distribution

Distributed nationwide in U.S.A., Australia and Canada.

Code Information

Lot # t01-16-2017@91, Exp 4/17/2017; t02-08-2017@93, Exp 4/30/2017.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated